Arrowstreet Capital, Limited Partnership Ligand Pharmaceuticals Inc Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $16.9 Million - $36.7 Million	-169,898 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $4.73 Million - $6.23 Million	-58,762 Reduced 25.7%	169,898 $16.9 Million
Q3 2020 Nov 12, 2020	BUY	$89.56 - $126.72 $6.24 Million - $8.83 Million	69,695 Added 43.84%	228,660 $21.8 Million
Q2 2020 Aug 12, 2020	BUY	$68.28 - $123.65 $9.02 Million - $16.3 Million	132,085 Added 491.39%	158,965 $17.8 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $1.7 Million - $2.9 Million	26,880 New	26,880 $1.96 Million

275

18.5M

28.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.03B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.